We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
VeriSign
VRSN
$25.5B
| $95.7M | 0.65% |
420,345
-3,792
| -0.9% | -$826K |
|
|
27
Intel
INTC
$464B
| $94.8M | 0.64% |
1,688,131
+1,506,939
| +832% | +$88.4M |
|
28
Travelers Companies
TRV
$80.8B
| $92.6M | 0.63% |
618,236
+58,440
| +10% | +$9.07M |
|
29
NetApp
NTAP
$32.9B
| $89.4M | 0.61% |
1,093,174
+114,156
| +12% | +$8.92M |
|
|
BNY
30
Bank of New York Mellon
BNY
$108B
| $89.1M | 0.6% |
1,738,964
+516,148
| +42% | +$25.8M |
|
31
Synaptics
SYNA
$4.41B
| $88.9M | 0.6% |
571,643
-60,619
| -10% | -$8.2M |
|
32
United Therapeutics
UTHR
$26.3B
| $88.1M | 0.6% |
490,859
-14,036
| -3% | -$2.67M |
|
|
VISN
33
Vistance Networks Inc
VISN
$2.66B
| $86.8M | 0.59% |
4,072,549
-170,263
| -4% | -$3.17M |
|
34
Incyte
INCY
$23.5B
| $85.3M | 0.58% |
1,014,263
+226,110
| +29% | +$18.9M |
|
35
Cencora
COR
$60.3B
| $84.3M | 0.57% |
736,191
+24,193
| +3% | +$2.86M |
|
36
Domino's
DPZ
$11B
| $84M | 0.57% |
180,031
+21,952
| +14% | +$9.31M |
|
37
Capital One
COF
$124B
| $81.9M | 0.56% |
529,266
-281,123
| -35% | -$42.4M |
|
38
Tyson Foods
TSN
$20.2B
| $80.9M | 0.55% |
1,097,276
+574,165
| +110% | +$44.5M |
|
39
AutoZone
AZO
$48.3B
| $80.5M | 0.55% |
53,916
-23,548
| -30% | -$34.1M |
|
40
Hershey
HSY
$35.4B
| $78.7M | 0.53% |
451,861
+4,331
| +1% | +$729K |
|
|
41
Prudential Financial
PRU
$41.7B
| $78.2M | 0.53% |
763,437
+711,279
| +1,364% | +$72.7M |
|
42
Cable One
CABO
$213M
| $74.5M | 0.5% |
38,936
-1,920
| -5% | -$3.45M |
|
43
Kinder Morgan
KMI
$73.1B
| $73.1M | 0.5% |
4,007,628
+912,418
| +29% | +$16.3M |
|
44
Goodyear
GT
$2.07B
| $72.7M | 0.49% |
4,236,485
+23,701
| +0.6% | +$437K |
|
45
Bunge Global
BG
$23.6B
| $72.4M | 0.49% |
926,234
+64,738
| +8% | +$5.47M |
|
46
Reinsurance Group of America
RGA
$15.7B
| $71.4M | 0.48% |
626,106
+133,940
| +27% | +$16.9M |
|
|
BRSL
47
Brightstar Lottery PLC
BRSL
$1.91B
| $70.3M | 0.48% |
2,934,358
+447,311
| +18% | +$9.37M |
|
48
Vistra
VST
$55.1B
| $70.3M | 0.48% |
3,789,150
+2,185,664
| +136% | +$37.7M |
|
49
Targa Resources
TRGP
$60.4B
| $69.7M | 0.47% |
1,568,811
+23,389
| +2% | +$905K |
|
50
Arrow Electronics
ARW
$10.9B
| $69.7M | 0.47% |
612,050
+138,266
| +29% | +$16.2M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.